Green Arrow Capital Management’s KYTHERA BIOPHARMACEUTICALS, INC COM KYTH Stock Holding History

Green Arrow Capital Management’s Portfolio KYTH Stock Details KYTH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q4	–	Sell	-20,000	Closed	-$655K	–	203
2014 Q3	$655K	Sell	20,000 -8,000	-29%	-$282K	0.06%	155
2014 Q2	$1.07M	Sell	28,000 -7,000	-20%	-$244K	0.14%	134
2014 Q1	$1.39M	Sell	35,000 -20,000	-36%	-$895K	0.12%	171
2013 Q4	$2.05M	Buy	+55,000	New	+$2.28M	0.14%	171

Other funds holding KYTH

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

PHS

PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

KCM

Kornitzer Capital Management Shawnee Mission, Kansas $4.79B AUM 30.56% 1-Year Est. Return

Green Arrow Capital Management's KYTH Position: Q4 2014 in Review

Green Arrow Capital Management sold out of KYTHERA BIOPHARMACEUTICALS, INC COM (KYTH) in Q4 2014, closing a stake of 20,000 shares — an estimated $655K sold.

Green Arrow Capital Management first reported a position in KYTH in Q4 2013 and held it in 4 quarters. The position peaked at $2.05M in Q4 2013. 106 funds tracked by Wall St. Rank hold KYTH as of Q4 2014.

Green Arrow Capital Management reported no remaining KYTHERA BIOPHARMACEUTICALS, INC COM position as of Q4 2014 after selling out during the quarter.
Green Arrow Capital Management sold 20,000 KYTHERA BIOPHARMACEUTICALS, INC COM shares in Q4 2014, an estimated $655K.
Green Arrow Capital Management first reported a position in KYTHERA BIOPHARMACEUTICALS, INC COM in Q4 2013 and held it in 4 quarters.
Green Arrow Capital Management's KYTHERA BIOPHARMACEUTICALS, INC COM position peaked at $2.05M in Q4 2013.
106 funds tracked by Wall St. Rank held KYTHERA BIOPHARMACEUTICALS, INC COM as of Q4 2014.

Based on Green Arrow Capital Management's 13F filing for Q4 2014, filed 17 Feb 2015.